ORF Biologics, Inc. Launches High-Quality CHO-K1 and HEK293 Cells with Optimized Growth Media

Tiffin, Iowa — [May 12, 2025] – ORF Biologics, Inc., Iowa’s leading provider of cells, growth factors, biotechnology tools, and reagents, proudly announces the immediate availability of standard CHO-K1 and HEK293 cell lines, accompanied by custom-matched growth media designed for optimal performance in both research and production environments.

These two cell lines—Chinese Hamster Ovary (CHO-K1) and Human Embryonic Kidney 293 (HEK293)—are widely regarded as foundational systems in the biopharmaceutical industry, serving as bulwarks in recombinant protein and monoclonal antibody production. Now, researchers and manufacturers can access them from ORF Biologics with the assurance of excellent quality control, fair pricing, and responsive technical support.

“CHO and HEK cells are the backbone of modern biologics,” said Anant Kamath, CEO of ORF Biologics, Inc. “We’re thrilled to make these high-performance lines available to the biotech community, especially at a time when reliable access and service have never been more important. Our goal is simple: make powerful, dependable cell systems available to anyone doing important work in this space—without the usual markups or delays.”

Reliable Tools for Critical Work

Both CHO-K1 and HEK293 cells offered by ORF Biologics are authenticated, high-viability stocks, maintained under rigorous standards and shipped with detailed protocols. The growth media, formulated specifically to complement each cell type, supports robust cell health, rapid adaptation, and reproducible performance across R&D and early production settings.
These offerings are ideal for:

  • Transient and stable transfection workflows
  • Recombinant protein and antibody production
  • Biological assay development
  • High-throughput screening and testing

In-house testing has demonstrated superlative doubling times, minimal adaptation periods, and high expression efficiency using the company’s media kits, which are available in standard and animal-origin-free formats.

A Commitment to Service and Expansion

“Every product we release is backed by technical expertise and personal support,” added Kamath. “We know what it’s like to need quick answers and dependable tools. That’s the standard we hold ourselves to.”

ORF Biologics encourages researchers, CDMOs, and academic labs to inquire about bulk pricing, distributor partnerships, and integration into larger workflows. This launch also marks the beginning of a broader initiative: a streamlined, high-impact product line tailored to protein production, assay development, and therapeutic R&D.

“Stay tuned,” Kamath added. “We’re just getting started. Our next wave of products is right around the corner.”

About ORF Biologics, Inc.

Based in Tiffin, Iowa, ORF Biologics, Inc. is Iowa’s leading provider of cells, growth factors, biotechnology tools, and reagents. With decades of combined experience, deep technical know-how, and a passion for making biology work better, ORF Biologics is building a new kind of biotech resource: agile, affordable, and uncompromising on quality.
Media Contact:
Anant Kamath, CEO
ORF Biologics, Inc.
1110 Tall Grass Avenue,
Tiffin, Iowa 52340
(319) 992-0001
contact@orfbiologics.com